Driving In Situ Hybridization Market Growth in 2025: The Role of The Surging Role Of In-Situ Hybridization In Tackling Infectious Diseases

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

In Situ Hybridization Market Size Growth Forecast: What to Expect by 2025?
The market size for in situ hybridization has seen robust growth in the past few years. It is predicted to increase from $1.68 billion in 2024 to $1.81 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The significant growth during the historical period could be credited to its early adoption for scientific research, advancement in molecular biology tools, progress in developing diagnostic applications, a shift towards biomedical research, and a rise in biotechnological investments.

How Will the In Situ Hybridization Market Size Evolve and Grow by 2029?
Expectations are high for the in situ hybridization market to experience significant expansion in the coming years. With a projected compound annual growth rate (CAGR) of 11.1%, the market is estimated to reach $2.76 billion by 2029. The primary drivers of this growth during the forecast period are increased usage in clinical diagnostics, enhancements in research and development funding, the introduction of automated and high-throughput solutions, and wider application in the fields of neuroscience and pathology. The period is also set to witness trends including progression in molecular biology, a surge in demand for research applications, expansion of diagnostic applications, growing demand for personalized medicine, and increased investment in biomedical research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

What Drivers Are Propelling the Growth of In Situ Hybridization Market Forward?
The escalating prevalence of contagious diseases is predicted to fuel the expansion of the in-situ hybridization market. These types of diseases, which are typically spread through contaminated food, drinks, or pathogens like bacteria, viruses, fungi, and parasites, can be identified using labeled nucleic acid sequences (probes) specific to the offending organism through in-situ hybridization (ISH). Hence, the surge in infectious diseases propels the in-situ hybridization market's growth. For instance, the Centers for Disease Control and Prevention, an American government agency, indicated in March 2024 that tuberculosis cases escalated from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Consequently, the rising occurrence of infectious diseases is stimulating the development of the in-situ hybridization market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

What Are the Key Trends Driving In Situ Hybridization Market Growth?
Leading firms in the in situ hybridization industry are concentrating on the creation of innovative solutions such as RNA detection assays to boost gene therapy progression. RNA detection assays, molecular methods used to identify and measure specific RNA molecules in a given sample, facilitate the study of gene expression, viral infections, and other RNA-related biological processes. For example, Bio-Techne Corporation, a life sciences enterprise based in the United States, introduced the RNAscope Plus smRNA-RNA detection assay in January 2023. This is a contemporary in situ hybridization tool that allows for the concurrent fluorescent detection of small regulatory RNAs like microRNAs (miRNAs), along with three target RNAs or RNA biomarkers within the same tissue section. This assay has been devised for scalability to support large studies and can be used on the Leica Bond Rx platform or manually. It delivers single-cell and subcellular resolution, thereby aiding researchers to effectively evaluate the biodistribution and functionality of cutting-edge gene therapies and endogenous regulatory RNAs. Furthermore, this assay integrates proprietary RNAscope and miRNAscope technologies to significantly enhance the comprehension of gene expression and cellular responses, providing crucial insights for the development of tailor-made gene therapies for inherited or acquired diseases.

What Are the Key Segments in the In Situ Hybridization Market?
The in situ hybridization market covered in this report is segmented -

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products
2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)
3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications
5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems
2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents
3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services
4) By Other Products: Accessories, Control Samples, Maintenance Supplies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Who Are the Key Players Shaping the In Situ Hybridization Market's Competitive Landscape?
Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton dic*kinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

What Geographic Markets Are Powering Growth in the In Situ Hybridization Market?
North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24571

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.